A Multicenter Study to Evaluate Safety and Immunogenicity of a Live-attenuated Chikungunya Vaccine in Adolescents
Clinical trial NCT04650399 · COMPLETED
Trial details
- NCT number
- NCT04650399
- Sponsor
- Butantan Institute
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-14
- Primary completion
- 2023-03-14
- Enrollment
- 754
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.